Conference Proceedings

Immunologic profiling and clinical outcome in HER2 breast cancer patients treated in a neoadjuvant phase II study: A step forward to understand trastuzumab activity

R Dolcetti, D Crivellari, E Muraro, D Martorelli, G Miolo, D Lombardi, S Massarut, T Perin, R Talamini, E Turchet, E Comaro, A Carbone, A Veronesi

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2011

DOI: 10.1200/jco.2011.29.15_suppl.e11083

Keywords

Science & Technology
Life Sciences & Biomedicine
Oncology